WO2024250040 - COVID VACCINE DELIVERED BY HD-MAP

National phase entry is expected:
Publication Number WO/2024/250040
Publication Date 05.12.2024
International Application No. PCT/US2024/039247
International Filing Date 24.07.2024
Title **
[English] COVID VACCINE DELIVERED BY HD-MAP
[French] VACCIN CONTRE LA COVID ADMINISTRÉ PAR HD-MAP
Applicants **
VAXXAS PTY LIMITED Suite 304, Level 3, 1 Alfred Street Sydney, NSW, 2000, AU
HOEY, David Suite 304, Level 3, 1 Alfred Street Boston, MA 02115, US
Inventors
BERMINGHAM, Imogen Vaxxas Pty Limited Suite 304, Level 3, 1 Alfred Street Sydney, Nsw, 2000, AU
FORSTER, Angus Vaxxas Pty Limited Suite 304, Level 3, 1 Alfred Street Sydney, Nsw, 2000, AU
BAKER, Ben Vaxxas Pty Limited Suite 304, Level 3, 1 Alfred Street Sydney, Nsw, 2000, AU
MULLER, David Vaxxas Pty Limited Suite 304, Level 3, 1 Alfred Street Sydney, Nsw, 2000, AU
MURUGAPPAN, Senthil Vaxxas Pty Limited Suite 304, Level 3, 1 Alfred Street Sydney, Nsw, 2000, AU
Priority Data
63/470,600   02.06.2023   US
front page image
Application details
Total Number of Claims/PCT *
Number of Independent Claims *
Number of Priorities *
Number of Multi-Dependent Claims *
Number of Drawings *
Pages for Publication *
Number of Pages with Drawings *
Pages of Specification *
*
*
International Searching Authority
*
*
Applicant's Legal Status
*
*
*
*
*
Entry into National Phase under
*
Translation

Recalculate

* The data is based on automatic recognition. Please verify and amend if necessary.

** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.

Quotation for National Phase entry

Country StagesTotal
China Filing1155
EPO Filing, Examination6742
Japan Filing597
South Korea Filing575
USA Filing, Examination2280
MasterCard Visa

Total: 11349

The term for entry into the National Phase has expired. This quotation is for informational purposes only

Abstract[English] A method of immunizing a human against SARS-CoV-2 by administering to the human a HexaPro vaccine composition coated onto a microprojection array (HD-MAP) comprising a base and a plurality of solid microprojections by projecting the microprojection array into the human's skin thereby penetrating the skin with the microprojections coated with the composition such that the vaccine composition is stripped from the microprojections.[French] L'invention concerne une méthode d'immunisation d'un être humain contre le SARS-CoV-2 par l'administration à l'être humain d'une composition vaccinale HexaPro qui enduit un réseau de microprojections (HD-MAP) comprenant une base et une pluralité de microprojections solides, par projection du réseau de microprojections dans la peau de l'être humain et par pénétration dans la peau des microprojections enduites de la composition en sorte de retirer la composition vaccinale des microprojections.
An unhandled error has occurred. Reload 🗙